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Background: Efficacy of cardiac resynchronization therapy (CRT) for patients with chronic atrial fibrillation (CAF) has not been fully evaluated.
Methods & Results: CUBIC study is a multi-center registry of Japanese patients undergoing CRT between Apr. 2004 and Dec. 2008. Data of 680 
patients from 11 institutions were available. The population of this study consisted of 445 patients with baseline LVEF≤45% and paired UCG data 
(at baseline and 6 months after CRT). We compared improvement in LV function between patients with and without CAF (74 and 371patients, 
respectively). The baseline characteristics were as follows; Age: 72 vs. 68 (years); Male: 74 vs. 68 (%); NYHA IV: 12 vs. 11 (%);Previous PM: 53 vs 29 
(%)*; Diabetes: 30 vs 33 (%);Creatinine > 1.5 (mg/dl): 31 vs 26 (%); IHD: 20 vs. 31 (%); LVEF: 29 vs. 26 (%);LVEDV: 201 vs 214 (ml) BNP: 554 vs. 
678 (pg/dl); QRS duration:154 vs. 147 (msec); (CAF vs. non-CAF, *p<0.05). LVEDV decreased by ≥10% in 50% and 58% (P=0.21), LVESV decreased 
by ≥15% in 54% and 56% (P=0.73), and LVEF increased by ≥25% in 45% and 44% (P=0.92), respectively.
Conclusions: CRT was equally effective in patients with and without CAF, in terms of similar degree of improvement in LV function.
CAF vs. non-CAF
CAF non-CAF p value
pre LVEDV 201 ml 214 ml 0.26
6Mo LVEDV 177 ml 184 ml 0.64
decrease in LVEDV ≥10% 50 % 58 % 0.21
pre LVESV 146 ml 161 ml 0.07
6Mo LVESV 119 ml 130 ml 0.22
decrease in LVESV ≥15% 54 % 56 % 0.73
pre LVEF 29 % 26 % 0.003
6Mo LVEF 35 % 33 % 0.04
increase in LVEF ≥25% 45 % 44 % 0.92
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